Trinity Capital Commits $35 Million to Monteris Medical for Growth Capital

Written by Emily J. Thompson, Senior Investment Analyst

Source: PRnewswire

Updated: Mar 12 2026

0mins

TRIN+0.56%

Should l Buy TRIN?

Source: PRnewswire

Investment Scale: Trinity Capital has committed $35 million to Monteris Medical to support the commercialization of its NeuroBlate System and the expansion of clinical research, thereby driving innovation in medical technology.
Technological Advantage: The NeuroBlate System utilizes robotically controlled laser interstitial thermal therapy to precisely remove abnormal brain tissue, offering patients lower complication rates and shorter hospital stays compared to traditional open neurosurgery, significantly enhancing patient treatment experiences.
Market Outlook: Monteris Medical's technology is expanding treatment options in neurosurgery, and Trinity Capital's investment not only strengthens its market competitiveness but also reflects strong confidence in its strategy and technology, indicating a promising future in the life sciences sector.
Partnership Confidence: The CEO of Monteris Medical stated that this financing will accelerate growth and drive innovation, indicating that the collaboration with Trinity Capital will provide robust support for its clinical impact across neuroscience centers.

Trade with 70% Backtested Accuracy

Stop guessing "Should I Buy TRIN?" and start using high-conviction signals backed by rigorous historical data.

Analyst Views on TRIN

Wall Street analysts forecast TRIN stock price to rise

6 Analyst Rating

5 Buy

0 Hold

1 Sell

Moderate Buy

Current: 14.370

Low

13.50

Averages

16.50

High

17.50

Current: 14.370

Low

13.50

Averages

16.50

High

17.50

Clear Street

Mickey Schleien

Buy

initiated

$18

2026-02-04

Reason

Clear Street

Mickey Schleien

Price Target

$18

AI Analysis

2026-02-04

initiated

Buy

Reason

Clear Street analyst Mickey Schleien initiated coverage of Trinity Capital with a Buy rating and $18 price target. In the internally managed business development company universe, the firm sees Trinity combining strong portfolio yields, solid dividend coverage, and emerging fee-based earnings optionality and trading at a discount to peers, the analyst tells investors.

Citizens

Outperform

maintain

$19

2026-01-27

Reason

Citizens

Price Target

$19

2026-01-27

maintain

Outperform

Reason

Citizens raised the firm's price target on Trinity Capital to $19 from $17.50 and keeps an Outperform rating on the shares. The private capital industry is adjusting to a new operating backdrop marked by lower interest rates, creating mixed impacts across products but underscoring the importance of understanding underlying earnings drivers, the analyst tells investors in a research note. Scale and diversification should support resilient growth into 2026, making manager selection increasingly critical despite expectations for continued industry expansion, the firm says.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for TRIN

Unlock Now

About TRIN

Trinity Capital Inc. is an internally managed, closed-end, non-diversified management investment company that operates as a business development company. It is a specialty lending company that provides debt, including loans and equipment financings, to growth-stage companies, including venture-backed companies and companies with institutional equity investors. Its investment objective is to generate current income and capital appreciation through its investments across five vertical markets. It seeks to achieve its investment objective by making investments consisting primarily of term loans and equipment financings and working capital loans, equity and equity-related investments. Its equipment financings involve loans for general or specific use, including acquiring equipment that is secured by the equipment or other assets of the portfolio company. It targets investments in growth-stage companies that are typically private companies, including institutional investor-based companies.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

Trinity Capital Dividend Investment Analysis

5 hours agoNASDAQ.COM

Dividend Investment Strategy: The report highlights that value-oriented dividend investors typically focus on companies with strong profitability and attractive valuations, with Trinity Capital Inc being one such company.
Dividend Payment Status: Trinity Capital Inc currently pays an annualized dividend of $2.04 per share in monthly installments, reflecting its stable cash flow and profitability, which appeals to income-seeking investors.
Importance of Dividend History: The report emphasizes that studying a company's historical dividend payments is crucial for assessing the likelihood of continued dividends, with Trinity Capital's long-term dividend history providing significant insights for investors.
Investment Research Tool: By utilizing a proprietary DividendRank formula, the report aims to generate a list of 'interesting' stocks based on profitability and valuation, serving as a resource for investors to conduct further research.

Trinity Capital Commits $50M to Sage Health for Growth

4 days agoseekingalpha

Capital Commitment: Trinity Capital announced a $50 million growth capital investment in Sage Health, a full-risk primary care provider for Medicare-eligible seniors, enhancing its competitive position in the healthcare market.
Market Expansion: The funding will support Sage Health's geographic expansion into new medically underserved areas, aiming to increase the reach of its senior-focused care platform to meet rising market demand.
Total Financing: This investment brings Sage Health's total capital raised to $170 million to date, demonstrating investor confidence in its business model and market potential, thereby solidifying its position in the industry.
Stock Price Reaction: Trinity Capital's stock fell 0.089% in premarket trading to $14.517, reflecting the market's initial reaction to the investment, which may influence its future capital management strategies.

Trinity Capital Invests $50 Million in Sage Health for Senior Care Expansion

4 days agoPRnewswire

Capital Injection: Trinity Capital announces a $50 million investment in Sage Health to support its expansion in medically underserved areas, aiming to enhance the quality of care for Medicare-eligible seniors, which is expected to significantly improve health management outcomes.
Integrated Care Model: Sage Health's approach, where each physician manages no more than 500 patients, allows for personalized care, aiming to improve patients' quality of life and life expectancy through longer visits and intensive chronic condition management.
Total Capital Raised: This financing brings Sage Health's total capital raised to $170 million, indicating the company's ongoing appeal and market potential in the senior healthcare sector, which is expected to drive its expansion into new markets.
Strategic Partnership: Trinity Capital's investment not only provides financial support but also leverages its expertise in the healthcare sector through close collaboration with Sage Health, aiming to drive positive outcomes across the industry and further solidify their partnership.

Trinity Capital Commits $50 Million to Sage Health for Growth Capital

4 days agoNewsfilter

Capital Injection: Trinity Capital announces a $50 million investment in Sage Health aimed at supporting its expansion in medically underserved areas, enhancing the quality and accessibility of healthcare for elderly patients.
Market Demand: Sage Health focuses on providing comprehensive primary care services for Medicare-eligible seniors, with physicians managing no more than 500 patients each, allowing for longer visits and intensive management of chronic conditions.
Total Capital Raised: This financing brings Sage Health's total capital raised to $170 million, reflecting investor confidence in its innovative healthcare model and is expected to drive further development in new markets.
Strategic Partnership: Trinity Capital's investment not only provides financial support but also fosters close collaboration with Sage Health, aiming to achieve more meaningful outcomes in the healthcare industry and enhance the overall quality of senior healthcare services.

Trinity Capital Declares Consistent Dividends for Q2 2026

Mar 18 2026PRnewswire

Consistent Dividends: Trinity Capital has declared a monthly dividend of $0.17 per share for April, May, and June 2026, maintaining over six years of stable dividends, which reflects the company's strong cash flow and profitability.
Dividend Payment Schedule: The payment dates for dividends in April, May, and June 2026 are set for April 30, May 29, and June 30, respectively, ensuring timely returns for shareholders and enhancing investor confidence.
Tax Compliance Objective: The company aims to distribute dividends approximating 90% to 100% of its taxable quarterly income to qualify as a regulated investment company under the Internal Revenue Code of 1986, ensuring tax compliance.
Portfolio Performance: Since its inception in 2008, Trinity Capital has deployed over $5.5 billion across 463 investments, showcasing its robust presence in the private credit market and ongoing growth potential.